Sunday, September 27, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 28, 2025

GE HealthCare CEO Peter Arduini is forging a new chapter for the $20 billion-a-year business while drawing on Jack Welch’s legacy

View original at finance.yahoo.com
GE HealthCare CEO Peter Arduini is forging a new chapter for the $20 billion-a-year business while drawing on Jack Welch’s legacy On Jan. 4, 2023, GE HealthCare Technologies (No…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Innovation requires a 3 to 5 year cycle in the medical technology business

    80% confidence
  • Larry Culp characterized himself as a down-to-earth, focused, and intentional leader

    80% confidence
  • GE HealthCare stock is up almost 50% since IPO on January 4, 2023

    80% confidence
  • As a standalone company, GE HealthCare can make decisions faster with better focus and less noise

    80% confidence
  • Authenticity and direct communication are critical for CEOs in today's world with younger employee base and social media

    80% confidence
  • GE gave employees bold assignments at a very young age and had a tough but fair culture under Jack Welch

    80% confidence
  • R&D investment doubled from $750-800 million in 2018 to over $1.4 billion currently

    80% confidence
  • Harmony between China and the U.S. is beneficial for the world and necessary for GE HealthCare to reach full potential

    80% confidence
  • Med tech is an American gem with 70%+ of products made in the United States and majority of IP originating there

    80% confidence
  • GE HealthCare reduced China imports from 75% to now making 85-90% of products locally for the China market

    80% confidence
  • China will eventually become the largest healthcare market with 1.4 billion people

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI Agents Scale Up Through Partnerships and Funding, But Data Readiness Lags Ambition
A wave of vertical AI-agent startups (Swarm, Veridox, Avallon AI, DA2, F2, Earthian, Meanwhile, Covecta, Penguin AI, Maisa AI) is being funded and profiled just as major infrastructure players — Microsoft/Mistral, Siemens/NVIDIA, and Manulife/Microsoft — cement enterprise AI governance and compute partnerships. Yet a Google Cloud report shows AI agents still lack access to the majority of company data (only 45% on average), and insider selling at incumbent C3.ai signals investor caution even as adoption intent (100% planned agentic AI use within two years) races ahead of actual data infrastructure.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,984
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,984 facts checked against source5,306 source documents archived
Query this data → isubstrate.com